Literature DB >> 11920857

Correlation between serotonin uptake in human blood platelets with the 44-bp polymorphism and the 17-bp variable number of tandem repeat of the serotonin transporter.

Rolf Kaiser1, Bruno Müller-Oerlinghausen, Diana Filler, Pierre-Benoit Tremblay, Anne Berghöfer, Ivar Roots, Jürgen Brockmöller.   

Abstract

Dysfunctions of the central serotonin (5-hydroxytryptamine, 5-HT) system seem to be associated with psychiatric disorders such as schizophrenia or depression. Previous studies suggested that a 44-bp insertion/deletion polymorphism of the 5-HT transporter (5-HTT) promoter region might influence the transcriptional activity of the 5-HTT gene, and the insertion variant resulted in increased 5-HTT expression and 5-HT uptake. Moreover, a 17-bp variable number of tandem repeat (VNTR) polymorphism of the second intron may act as a transcriptional regulator with allele dependent differential enhancer-like properties. Since the 5-HTT of human platelets shares many properties with the transporter of neural tissue, platelets are widely used as a surrogate tissue source, possibly reflecting central 5-HT metabolism. Therefore, we investigated the impact of the 44-bp polymorphism and the 17-bp VNTR for 5-HT uptake in platelets of 50 male subjects. We found no significant effect of the 44-bp polymorphism and of the 17-bp VNTR on maximum rate (Vmax) of 5-HT uptake. However, individuals homozygous for the 5-HTT intron 2 allele with 12 repeats (STin2.12) of the 17-bp VNTR appeared to have lower affinity of 5-HT uptake than individuals heterozygous for the STin2.10/STin2.9 allele. This was also observed for the combined analysis of both polymorphisms. In conclusion, we found no association between the different genotypes of the 44-bp polymorphism and the 17-bp VNTR and maximum rate of 5-HT uptake into platelets. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11920857     DOI: 10.1002/ajmg.10119

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  20 in total

1.  Serotonin transporter gene (SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients.

Authors:  Aarthi Manoharan; Deepak Gopal Shewade; Ravi Philip Rajkumar; Surendiran Adithan
Journal:  Eur J Clin Pharmacol       Date:  2016-07-20       Impact factor: 2.953

2.  Boron-Doped Diamond Microelectrodes Reveal Reduced Serotonin Uptake Rates in Lymphocytes from Adult Rhesus Monkeys Carrying the Short Allele of the 5-HTTLPR.

Authors:  Yogesh S Singh; Lauren E Sawarynski; Heather M Michael; Robert E Ferrell; Michael A Murphey-Corb; Greg M Swain; Bhavik A Patel; Anne M Andrews
Journal:  ACS Chem Neurosci       Date:  2010-01-20       Impact factor: 4.418

3.  Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism.

Authors:  Francis E Lotrich; Robert E Ferrell; Mordechai Rabinovitz; Bruce G Pollock
Journal:  Biol Psychiatry       Date:  2008-09-18       Impact factor: 13.382

4.  A polymorphism in the serotonin transporter gene moderates cardiovascular reactivity to psychosocial stress.

Authors:  Baldwin M Way; Shelley E Taylor
Journal:  Psychosom Med       Date:  2011-03-01       Impact factor: 4.312

5.  Interaction analysis between 5-HTTLPR and TNFA -238/-308 polymorphisms in schizophrenia.

Authors:  C-U Pae; A Serretti; P Artioli; T-S Kim; J-J Kim; C-U Lee; S-J Lee; I-H Paik; C Lee
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

Review 6.  Role of the 5-HTTLPR and SNP Promoter Polymorphisms on Serotonin Transporter Gene Expression: a Closer Look at Genetic Architecture and In Vitro Functional Studies of Common and Uncommon Allelic Variants.

Authors:  Sandra Iurescia; Davide Seripa; Monica Rinaldi
Journal:  Mol Neurobiol       Date:  2015-10-13       Impact factor: 5.590

7.  Haplotype structure and divergence at human and chimpanzee serotonin transporter and receptor genes: implications for behavioral disorder association analyses.

Authors:  Katrina G Claw; Raul Y Tito; Anne C Stone; Brian C Verrelli
Journal:  Mol Biol Evol       Date:  2010-01-29       Impact factor: 16.240

8.  Predictive index for the onset of medication overuse headache in migraine patients.

Authors:  T Onaya; M Ishii; H Katoh; S Shimizu; H Kasai; M Kawamura; Y Kiuchi
Journal:  Neurol Sci       Date:  2013-01       Impact factor: 3.307

9.  Clinical implications of genetic variation in the serotonin transporter promoter region: a review.

Authors:  Nicole S Luddington; Anitha Mandadapu; Margaret Husk; Rif S El-Mallakh
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

10.  Combinatorial interaction between two human serotonin transporter gene variable number tandem repeats and their regulation by CTCF.

Authors:  Fahad R Ali; Sylvia A Vasiliou; Kate Haddley; Ursula M Paredes; Julian C Roberts; Fabio Miyajima; Elena Klenova; Vivien J Bubb; John P Quinn
Journal:  J Neurochem       Date:  2009-10-26       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.